These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
489 related articles for article (PubMed ID: 30876658)
1. Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial). Patel RB; Vaduganathan M; Felker GM; Butler J; Redfield MM; Shah SJ Am J Cardiol; 2019 May; 123(10):1660-1666. PubMed ID: 30876658 [TBL] [Abstract][Full Text] [Related]
2. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume. Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355 [TBL] [Abstract][Full Text] [Related]
4. Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices. Snipelisky D; Kelly J; Levine JA; Koepp GA; Anstrom KJ; McNulty SE; Zakeri R; Felker GM; Hernandez AF; Braunwald E; Redfield MM Circ Heart Fail; 2017 Jun; 10(6):e003878. PubMed ID: 28588021 [TBL] [Abstract][Full Text] [Related]
5. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status. Kristensen SL; Mogensen UM; Jhund PS; Rørth R; Anand IS; Carson PE; Desai AS; Pitt B; Pfeffer MA; Solomon SD; Zile MR; Køber L; McMurray JJV Circ Heart Fail; 2019 Mar; 12(3):e005766. PubMed ID: 30871349 [TBL] [Abstract][Full Text] [Related]
6. Persistent atrial fibrillation in heart failure with preserved ejection fraction: Prognostic relevance and association with clinical, imaging and invasive haemodynamic parameters. Schönbauer R; Duca F; Kammerlander AA; Aschauer S; Binder C; Zotter-Tufaro C; Koschutnik M; Fiedler L; Roithinger FX; Loewe C; Hengstenberg C; Bonderman D; Mascherbauer J Eur J Clin Invest; 2020 Feb; 50(2):e13184. PubMed ID: 31732964 [TBL] [Abstract][Full Text] [Related]
7. Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction. Savarese G; Orsini N; Hage C; Dahlström U; Vedin O; Rosano GMC; Lund LH J Card Fail; 2018 Jun; 24(6):365-374. PubMed ID: 29597053 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation. Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV; Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174 [TBL] [Abstract][Full Text] [Related]
9. Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial. DeVore AD; McNulty S; Alenezi F; Ersboll M; Vader JM; Oh JK; Lin G; Redfield MM; Lewis G; Semigran MJ; Anstrom KJ; Hernandez AF; Velazquez EJ Eur J Heart Fail; 2017 Jul; 19(7):893-900. PubMed ID: 28194841 [TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction. Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction. Nolte K; Herrmann-Lingen C; Platschek L; Holzendorf V; Pilz S; Tomaschitz A; Düngen HD; Angermann CE; Hasenfuß G; Pieske B; Wachter R; Edelmann F ESC Heart Fail; 2019 Apr; 6(2):262-270. PubMed ID: 30784226 [TBL] [Abstract][Full Text] [Related]
12. History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure. Patel RB; Vaduganathan M; Rikhi A; Chakraborty H; Greene SJ; Hernandez AF; Felker GM; Redfield MM; Butler J; Shah SJ JACC Heart Fail; 2019 Jan; 7(1):47-55. PubMed ID: 30409707 [TBL] [Abstract][Full Text] [Related]
13. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity. Reddy YNV; Rikhi A; Obokata M; Shah SJ; Lewis GD; AbouEzzedine OF; Dunlay S; McNulty S; Chakraborty H; Stevenson LW; Redfield MM; Borlaug BA Eur J Heart Fail; 2020 Jun; 22(6):1009-1018. PubMed ID: 32150314 [TBL] [Abstract][Full Text] [Related]
14. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction. Salah K; Stienen S; Pinto YM; Eurlings LW; Metra M; Bayes-Genis A; Verdiani V; Tijssen JGP; Kok WE Heart; 2019 Aug; 105(15):1182-1189. PubMed ID: 30962192 [TBL] [Abstract][Full Text] [Related]
15. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction. Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458 [TBL] [Abstract][Full Text] [Related]
16. Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program. Petrie MC; Borlaug BA; Butler J; Davies MJ; Kitzman DW; Shah SJ; Verma S; Jensen TJ; Einfeldt MN; Liisberg K; Perna E; Sharma K; Ezekowitz JA; Fu M; Melenovský V; Ito H; Lelonek M; Kosiborod MN; J Am Coll Cardiol; 2024 Jul; 84(1):27-40. PubMed ID: 38819334 [TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-B-type natriuretic peptide in chronic heart failure: The impact of sex across the ejection fraction spectrum. Faxén UL; Lund LH; Orsini N; Strömberg A; Andersson DC; Linde C; Dahlström U; Savarese G Int J Cardiol; 2019 Jul; 287():66-72. PubMed ID: 31005415 [TBL] [Abstract][Full Text] [Related]
18. Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction. Buckley LF; Canada JM; Del Buono MG; Carbone S; Trankle CR; Billingsley H; Kadariya D; Arena R; Van Tassell BW; Abbate A ESC Heart Fail; 2018 Apr; 5(2):372-378. PubMed ID: 29345112 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction. Huang A; Qi X; Hou W; Qi Y; Zhao N; Liu K Acta Cardiol; 2018 Feb; 73(1):41-48. PubMed ID: 28944719 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: insights from the GALACTIC-HF trial. Docherty KF; McMurray JJV; Claggett BL; Miao ZM; Adams KF; Arias-Mendoza A; Cleland JGF; Diaz R; Echeverria Correa LE; Felker GM; Fonseca C; Li J; Metra M; Sliwa-Hahnle K; Solomon SD; Vandekerckhove HJ; Vinereanu D; Voors AA; Heitner SB; Kupfer S; Malik FI; Meng L; Teerlink JR Eur J Heart Fail; 2023 Feb; 25(2):248-259. PubMed ID: 36597719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]